Global Oncology Pipeline Set to Expand With Next-Generation Cancer Drug Innovation
Novartis will acquire UK-based Myricx Bio in a deal worth up to…
ADAP Crisis Task Force Strikes Deal to Widen Access to New HIV Pill
Merck has partnered with the ADAP Crisis Task Force to expand access…
New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
IFPMA urged continued global commitment to ending AIDS as a public health…
Boehringer Ingelheim launches three phase III trials in precision Oncology
Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
Antag Therapeutics has appointed obesity treatment expert Philip Just Larsen as Chief…
WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination
World Health Organization and Gilead Sciences have renewed their partnership through 2030…
Century Health Raises $5M Seed Round as AI-Powered Platform Achieves 97% Accuracy in Clinical Data Abstraction
Century Health has raised an oversubscribed $5 million seed round to expand…
